Private equity firm KKR has taken a large stake in Henry Schein and reached a deal to add members to the company's board, the distributor of medical products said on Wednesday. Shares of Henry Schein ...

BofA analyst Allen Lutz double upgraded Henry Schein (HSIC) to Buy from Underperform with a price target of $84, up from $69. The firm believes ...

Private equity firm KKR has taken a large stake in Henry Schein and plans to work with the distributor of medical products to improve its operations, the Wall Street Journal reported on Wednesday ...

This belief drove our collaboration with Henry Schein One, a division of Henry Schein, a leader in dental software solutions, to launch a dynamic new website designed to set the standard for ...

Henry Schein, Inc. (NASDAQ:HSIC) shares are trading higher on Wednesday. The medical and dental supplies distributor ...

Henry Schein (HSIC – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Allen Lutz from ...

A full-blown board challenge would dial up ... Henry Schein senior executives exited after only a few years on the job, including Jonathan Koch, former CEO of Henry Schein's Global Dental Group ...

KKR has made an investment in Henry Schein Inc, a Melville, New York-based provider of healthcare solutions to office-based dental and medical practitioners. Stanley Bergman serves as CEO of Henry ...

NEW YORK (Reuters) - Activist investor Ananym Capital Management plans to nominate as many as half a dozen directors to the board at Henry Schein, arguing the dental ... would dial up the pressure ...